CBS 2019
CBSMD教育中心
English

科学研究

科研文章

荐读文献

Novel developments in revascularization for left main coronary artery disease Effect of Side Branch Predilation in Coronary Bifurcation Stenting With the Provisional Approach - Results From the COBIS (Coronary Bifurcation Stenting) II Registry Impact of the complexity of bifurcation lesions treated with drug-eluting stents: the DEFINITION study (Definitions and impact of complEx biFurcation lesIons on clinical outcomes after percutaNeous coronary IntervenTIOn using drug-eluting steNts) Impact of Positive and Negative Lesion Site Remodeling on Clinical Outcomes : Insights From PROSPECT Stage B heart failure: management of asymptomatic left ventricular systolic dysfunction Prognostic implication of lipidomics in patients with coronary total occlusion undergoing PCI Pulmonary arterial hypertension in congenital heart disease: an epidemiologic perspective from a Dutch registry Cardiac Resynchronization Therapy in Inotrope-Dependent Heart Failure Patients - A Systematic Review and Meta-Analysis Significantly less inappropriate shocks in ischemic patients compared to non-ischemic patients: The S-ICD experience of a high volume single-center A new optical coherence tomography-based calcium scoring system to predict stent underexpansion
|<<... 74 75 76 77 78 79 80 ...>>|

Editorial2018 Jul;28(5):365-366.

JOURNAL：Trends Cardiovasc Med. Article Link

Novel developments in revascularization for left main coronary artery disease

Carreras ET, Bhatt DL. Keywords: DK CRUSH; LM bifurcation lesions; evidence-based

Article Link

Please click on the "Article Link" on the right to get access to this article.


Quotation

"When PCI is used to treat LM bifurcation lesions,

DK-CRUSH is the most reasonable evidence-based approach."


>CBS CBS 2019

> CBS 2019

> CBS 2019 注册

> CBS 2019 会议日程

> CBS 2019 学术征集

> CBS 2019 热点

 CBSMD

> CBSMD 网站注册

> 教育中心

> 荐读文献

> Top 10 阅读文献

> 文献导读
CBS 2019 CBS 2019 主席团 教育中心 科研动态
Copyright ⓒ CBS MD Nanjing China. All rights reserved. 京ICP备16025898号-11
联系我们| Top